{"id":59707,"date":"2024-02-28T06:11:23","date_gmt":"2024-02-28T06:11:23","guid":{"rendered":"https:\/\/medsname.com\/vanking-500-injection\/"},"modified":"2026-04-30T11:50:31","modified_gmt":"2026-04-30T11:50:31","slug":"vanking-500-injection","status":"publish","type":"product","link":"https:\/\/medsbase.com\/nb\/product\/vanking-500-injection\/","title":{"rendered":"Vanking 500 Injektjon"},"content":{"rendered":"

<\/p>\n

\n

\u26a1 Quick Answer \u2014 What is Vanking 500 Injection?<\/h3>\n

Vanking 500 Injection is an IV vancomycin injection for severe MRSA infections, endocarditis, and bacteraemia. Hospital use only. Therapeutic drug monitoring required. Manufactured under WHO-GMP standards.<\/p>\n<\/div>\n

Hvorfor bestille fra MedsBase?<\/strong> Skaffet fra en WHO-GMP-sertifisert produsent \u00b7 Diskret emballasje \u00b7 Verdensomspennende frakt \u00b7 1,400+ verifiserte kundeanmeldelser<\/a><\/div>\n

\ud83d\udce6 Hver ordre er dekket av v\u00e5r Reshipment Assurance Policy<\/strong><\/a> \u2014 hvis pakken din ikke ankommer innen 20 virkedager, sender vi ny.<\/p>\n

Hvorfor bestille fra MedsBase<\/h3>\n

V\u00e5re generiske legemidler kommer fra WHO-GMP-sertifiserte produsenter og sendes over hele verden i diskret, n\u00f8ytral emballasje \u2014 ingen legemiddelnavn p\u00e5 utsiden av pakken. Kortbetalinger h\u00e5ndteres av en regulert betalingsbehandler (kontoutskrifter viser en regulert kortbetalingsprosessor \u2014 aldri \u201cMedsBase\u201d eller noe legemiddelnavn). Krypto og SEPA bankoverf\u00f8rsel godtas ogs\u00e5. Hver ordre er dekket av v\u00e5r Reshipment Assurance Policy.<\/p>\n

Produktoppsummering<\/strong><\/p>\n

Vanking 500 Injektjon<\/em> is a medication containing the active ingredient Vancomycin Hydrochloride. It is a potent antibiotic used to treat severe bacterial infections caused by susceptible strains of bacteria. Vanking 500 Injektjon<\/em> is administered intravenously and is commonly prescribed in hospital settings under the supervision of healthcare professionals. This medication works by inhibiting the growth of bacteria, thereby stopping the spread of infection in the body.<\/p>\n

Bruk<\/strong><\/p>\n

Vanking 500 Injektjon<\/em> is indicated for the treatment of serious infections caused by susceptible strains of bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and other gram-positive bacteria. It is commonly used to treat infections such as bloodstream infections, pneumonia, endocarditis, and bone and joint infections. Vanking 500 Injektjon<\/em> is reserved for infections where other antibiotics have failed or are not suitable due to resistance or intolerance.<\/p>\n

Bruk anvisning<\/strong><\/p>\n

Vanking 500 Injektjon<\/em> is administered intravenously by a healthcare professional in a hospital or clinical setting. The dosage and duration of treatment will be determined by your healthcare provider based on the type and severity of the infection, as well as your age, weight, and kidney function. The injection is typically given slowly over a period of 60 minutes to minimize the risk of side effects.<\/p>\n

Virkem\u00e5te<\/strong><\/p>\n

Vancomycin, the active ingredient in Vanking 500 Injektjon<\/em>, works by inhibiting the synthesis of bacterial cell walls. It binds to the cell wall precursors, preventing the formation of peptidoglycan, a crucial component of bacterial cell walls. Without a functioning cell wall, bacteria are unable to maintain their structural integrity and eventually die. This bactericidal action helps to eradicate the infection and prevent its spread within the body.<\/p>\n

Dosering og administrering<\/strong><\/p>\n

Doseringen av Vanking 500 Injektjon<\/em> is based on your medical condition, kidney function, and response to treatment. It is usually administered at a dose of 15 to 20 mg\/kg every 8 to 12 hours for most infections. The infusion rate should not exceed 10 mg\/minute to minimize the risk of infusion-related reactions. Your healthcare provider will determine the appropriate dosage and duration of treatment for your specific infection.<\/p>\n

Fordeler<\/strong><\/p>\n

Vanking 500 Injektjon<\/em> offers several benefits in the treatment of serious bacterial infections. It is effective against a wide range of gram-positive bacteria, including MRSA, making it a valuable option for infections that do not respond to other antibiotics. The intravenous formulation ensures rapid delivery of the medication to the bloodstream, allowing for prompt treatment of severe infections. Additionally, Vanking 500 Injektjon<\/em> is generally well-tolerated when used as directed.<\/p>\n

Vanlige bivirkninger<\/strong><\/p>\n

Vanlige bivirkninger av Vanking 500 Injektjon<\/em> may include nausea, vomiting, diarrhea, fever, chills, and rash. Infusion-related reactions such as flushing, itching, and redness at the injection site may also occur. These side effects are usually mild and transient, but if they persist or worsen, inform your healthcare provider promptly. In rare cases, Vanking 500 Injektjon<\/em> may cause more severe side effects such as kidney damage or allergic reactions. Seek medical attention if you experience symptoms such as difficulty breathing, swelling of the face or throat, or severe diarrhea.<\/p>\n

Advarsler<\/strong><\/p>\n

Before using Vanking 500 Injektjon<\/em>, inform your healthcare provider if you have any allergies, kidney problems, or hearing loss. This medication should be used with caution in patients with pre-existing kidney disease, as it may cause kidney damage, especially if given in high doses or for prolonged periods. Your kidney function should be monitored regularly during treatment. Use Vanking 500 Injektjon<\/em> with caution in elderly patients, as they may be more susceptible to certain side effects.<\/p>\n

Oppbevaringsinformasjon<\/strong><\/p>\n

Vanking 500 Injektjon<\/em> should be stored at room temperature away from light and moisture. Do not freeze. Keep the vials in the original packaging until ready to use. Once reconstituted, the solution should be used immediately or refrigerated and used within 24 hours. Discard any unused portion of the solution according to local regulations.<\/p>\n

Ansvarsfraskrivelse:<\/strong><\/p>\n

V\u00e5r eneste hensikt er \u00e5 sikre at forbrukerne f\u00e5r informasjon som er fagfellevurdert, n\u00f8yaktig og p\u00e5litelig. Imidlertid b\u00f8r ikke informasjonen her brukes som erstatning for r\u00e5d fra en kvalifisert lege. Informasjonen som gis her er kun til informasjonsform\u00e5l. Den dekker kanskje ikke alle mulige bivirkninger, legemiddelinteraksjoner eller advarsler. Vennligst konsulter legen din og diskuter alle sp\u00f8rsm\u00e5l du har relatert til sykdom eller medisin. Vi \u00f8nsker \u00e5 st\u00f8tte, ikke erstatte, lege-pasient-forholdet.<\/p>\n

Vanlige sp\u00f8rsm\u00e5l<\/h2>\n

What is Vanking 500 Injection used for?<\/h3>\n

Vanking 500 Injection is intravenous vancomycin \u2014 a hospital-administered glycopeptide for serious gram-positive infections including MRSA bacteraemia, endocarditis, osteomyelitis, complicated skin\/soft-tissue infection, ventilator-associated pneumonia, and febrile neutropenia (empiric).<\/p>\n

Why does Vanking 500 Injection need IV administration?<\/h3>\n

Oral vancomycin is not absorbed and only treats gut infection (C. difficile). For systemic staphylococcal disease you need adequate serum levels \u2014 only achievable via IV (or rarely intraperitoneal) route.<\/p>\n

Why is therapeutic drug monitoring required?<\/h3>\n

Vancomycin has a narrow therapeutic window. Underdosing risks treatment failure and resistance; overdosing causes nephrotoxicity and ototoxicity. Modern dosing targets AUC\u2080\u2013\u2082\u2084 of 400\u2013600 mg\u00b7h\/L (or trough 15\u201320 mg\/L for serious infection) \u2014 adjusted by pharmacy under hospital supervision.<\/p>\n

What is 'red man syndrome'?<\/h3>\n

An infusion-rate-dependent histamine release causing flushing, pruritus, and hypotension during rapid IV vancomycin. Slow the infusion to over 60 minutes (or longer for higher doses); pre-medication with antihistamines may help. Distinct from true anaphylaxis.<\/p>\n

What monitoring is needed during a course of Vanking 500 Injection?<\/h3>\n

Renal function (serum creatinine, urine output) at baseline and at least twice weekly; serum vancomycin levels per protocol; complete blood count; consider audiometry for prolonged courses. Adjust dose for renal impairment and concurrent nephrotoxins.<\/p>\n

Can I take Vanking 500 Injection at home?<\/h3>\n

Vanking 500 Injection is a hospital\/inpatient drug. Outpatient parenteral antibiotic therapy (OPAT) programmes can administer IV vancomycin at home for selected patients with stable disease, established line access, and pharmacy-led monitoring.<\/p>\n

<\/p>\n

Other Anti-Infective Medications<\/h2>\n